Comments on: Single-Agent Actimid And Combination Actimid-Dexamethasone Regimens Are Promising Treatments For Relapsed Myeloma (ASH 2009)

By: kate else

kate else — Tue, 10 Jan 2012 19:43:32 +0000

Has actimid been approved yet???
It is 2012 now …is it on the market???

By: Jessica Langholtz

Jessica Langholtz — Mon, 21 Dec 2009 15:41:47 +0000

Dear Janice,

Actimid (pomalidomide) is still undergoing Phase 2 clinical trials for evaluation of its safety and efficacy for the treatment of multiple myeloma. A timeline has not yet been announced to indicate when Celgene, it’s manufacturer, will apply for FDA approval. We will keep you posted at The Myeloma Beacon when more information becomes known.

Best,
Jessica Langholtz

By: janice schmeeckle

janice schmeeckle — Mon, 21 Dec 2009 01:06:03 +0000

We have been reading about Pomalidomide for over two years. Any idea as to when they will seek FDA approval and get it to market? There are many people with MM that need this and other new meds to live.

Tahnk you,

Janice Schmeeckle